| Financial Year |
March 31 2023 |
| Monetary Funds |
774,493,776.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,364,127.95 |
| Accounts Receivable |
1,002,308,525.76 |
| Advances to Suppliers |
166,467,616.32 |
| Other Receivables |
17,773,681.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,527,688,052.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
83,794,526.48 |
| Total Current Assets |
4,404,578,261.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
148,858,878.31 |
| Long-term Equity Investment |
46,284,006.34 |
| Investment Properties |
-- |
| Fixed Assetes |
3,120,392,218.43 |
| Under-construction Projects |
1,606,039,558.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
654,313,149.87 |
| R&D expenses |
395,752,401.89 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
35,864,800.99 |
| Deferred Income Tax Assets |
188,253,731.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,256,921,391.44 |
| Total Assets |
10,661,499,653.10 |
| Short-Term Loans |
2,096,761,128.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
343,405,000.00 |
| Accounts Payable |
510,691,215.16 |
| Accounts Received In Advance |
3,427,354.22 |
| Employee Compensation Payable |
51,187,788.56 |
| Taxes Payable |
33,502,773.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,677,045.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,064,054.80 |
| Other Current Liabilities |
2,718,253.20 |
| Sub-Total of Current Liabilities |
3,160,687,471.52 |
| Long-term Loans |
1,777,283,019.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
457,356,333.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,167,740.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,653,991,174.83 |
| Total Liabilities |
5,814,678,646.35 |
| Paid-In Capital(Or Share Stock) |
683,146,921.00 |
| Capital Surplus |
1,936,240,157.29 |
| Surplus Reserve |
133,373,257.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,542,750,278.81 |
| Minority Stockholder's Interest |
489,668,524.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,357,152,482.49 |
| Owner's Equity（Stockholder's Equity） |
4,846,821,006.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,661,499,653.10 |
